Searcey M, McClean S, Madden B, McGown A T, Wakelin L P
Chemistry Department, University College Dublin, Belfield, Dublin, Ireland.
Anticancer Drug Des. 1998 Dec;13(8):837-55.
We have explored the potential antitumour activity of DNA-intercalating free radical generators based on compounds constructed from 9-anilinoacridine and chelidamic acid as an iron (II) binding centre. Here we describe their synthesis, DNA cleaving ability and activity against a panel of human tumour cell lines in culture. We also investigate their potential for use as DNA footprinting agents. Previous work has shown that the parent compound, FTP1, cleaves DNA in an essentially sequence neutral fashion and has modest cytotoxicity [Searcey, M., McClean, S., Madden, B. & Wakelin, L.P.G. (1997) Journal of the Chemical Society. Perkin Transactions, 2, 523]. Here we have equipped the acridine chromophore with an N,N-dimethylaminoethyl-4-carboxamide substituent, giving the threading agent FTP2, which confers selectivity for cleaving in GC-rich sequences, avoidance for binding to AT-tracts and 8-fold enhanced cytotoxicity compared with FTP1. Although this side chain bestows slow dissociation kinetics on DNA complexes of 9-anilinoacridines, it does not enhance the overall cutting efficiency of FTP2, implying that free-radical generation, DNA hydrogen abstraction and sugar fragmentation are fast compared with DNA-ligand complex lifetimes. FTP2 does not appear to be susceptible to resistance by the mdr phenotype in human ovarian carcinoma cells. We also report that FTP2 is an effective footprinting agent for GC-selective binding ligands and that it has some advantages over FTP1 in this regard.
我们研究了基于由9-苯胺基吖啶和白屈氨酸构建的化合物作为铁(II)结合中心的DNA嵌入自由基发生器的潜在抗肿瘤活性。在此,我们描述了它们的合成、DNA切割能力以及对一组培养的人类肿瘤细胞系的活性。我们还研究了它们用作DNA足迹试剂的潜力。先前的工作表明,母体化合物FTP1以基本序列中性的方式切割DNA,并且具有适度的细胞毒性[Searcey, M., McClean, S., Madden, B. & Wakelin, L.P.G. (1997) 《化学学会杂志。珀金 Transactions》, 2, 523]。在此,我们给吖啶发色团配备了一个N,N-二甲基氨基乙基-4-羧酰胺取代基,得到穿线剂FTP2,它对富含GC的序列切割具有选择性,避免与富含AT的区域结合,并且与FTP1相比细胞毒性增强了8倍。尽管这个侧链赋予了9-苯胺基吖啶的DNA复合物缓慢的解离动力学,但它并没有提高FTP2的整体切割效率,这意味着与DNA-配体复合物的寿命相比,自由基的产生、DNA氢提取和糖片段化是快速的。FTP2似乎不易受到人卵巢癌细胞中mdr表型的耐药性影响。我们还报告说,FTP2是一种用于GC选择性结合配体的有效足迹试剂,并且在这方面它比FTP1有一些优势。